190 related articles for article (PubMed ID: 19298566)
1. Ten-year follow-up of cardiac sympathectomy in a young woman with catecholaminergic polymorphic ventricular tachycardia and an implantable cardioverter defibrillator.
Makanjee B; Gollob MH; Klein GJ; Krahn AD
J Cardiovasc Electrophysiol; 2009 Oct; 20(10):1167-9. PubMed ID: 19298566
[TBL] [Abstract][Full Text] [Related]
2. Importance of ventricular tachycardia storms not terminated by implantable cardioverter defibrillators shocks in patients with CASQ2 associated catecholaminergic polymorphic ventricular tachycardia.
Marai I; Khoury A; Suleiman M; Gepstein L; Blich M; Lorber A; Boulos M
Am J Cardiol; 2012 Jul; 110(1):72-6. PubMed ID: 22481011
[TBL] [Abstract][Full Text] [Related]
3. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.
Wilde AA; Bhuiyan ZA; Crotti L; Facchini M; De Ferrari GM; Paul T; Ferrandi C; Koolbergen DR; Odero A; Schwartz PJ
N Engl J Med; 2008 May; 358(19):2024-9. PubMed ID: 18463378
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic left thoracic sympathectomy to prevent electrical storms in CPVT patients needing ICD placement.
Moray A; Kirk EP; Grant P; Camphausen C
Heart Lung Circ; 2011 Nov; 20(11):731-3. PubMed ID: 21478052
[TBL] [Abstract][Full Text] [Related]
7. Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation.
Pizzale S; Gollob MH; Gow R; Birnie DH
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1319-21. PubMed ID: 18554199
[TBL] [Abstract][Full Text] [Related]
8. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
[TBL] [Abstract][Full Text] [Related]
9. Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.
De Ferrari GM; Dusi V; Spazzolini C; Bos JM; Abrams DJ; Berul CI; Crotti L; Davis AM; Eldar M; Kharlap M; Khoury A; Krahn AD; Leenhardt A; Moir CR; Odero A; Olde Nordkamp L; Paul T; Rosés I Noguer F; Shkolnikova M; Till J; Wilde AA; Ackerman MJ; Schwartz PJ
Circulation; 2015 Jun; 131(25):2185-93. PubMed ID: 26019152
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
[TBL] [Abstract][Full Text] [Related]
11. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
13. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
[TBL] [Abstract][Full Text] [Related]
14. Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
Khoury A; Marai I; Suleiman M; Blich M; Lorber A; Gepstein L; Boulos M
Heart Rhythm; 2013 Nov; 10(11):1671-5. PubMed ID: 23954267
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.
Pott C; Dechering DG; Reinke F; Muszynski A; Zellerhoff S; Bittner A; Köbe J; Wasmer K; Schulze-Bahr E; Mönnig G; Kotthoff S; Eckardt L
Europace; 2011 Jun; 13(6):897-901. PubMed ID: 21292648
[TBL] [Abstract][Full Text] [Related]
16. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.
Alexander ME; Cecchin F; Walsh EP; Triedman JK; Bevilacqua LM; Berul CI
J Cardiovasc Electrophysiol; 2004 Jan; 15(1):72-6. PubMed ID: 15028076
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter defibrillator (ICD) in children.
Eicken A; Kolb C; Lange S; Brodherr-Heberlein S; Zrenner B; Schreiber C; Hess J
Int J Cardiol; 2006 Feb; 107(1):30-5. PubMed ID: 16337494
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
[TBL] [Abstract][Full Text] [Related]
19. Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias.
Hofferberth SC; Cecchin F; Loberman D; Fynn-Thompson F
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):404-9. PubMed ID: 24268954
[TBL] [Abstract][Full Text] [Related]
20. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
